HOXD12 defines an age-related aggressive subtype of oligodendroglioma.

Acta Neuropathol · 2024 · PMC11390787 · PMID 39259414

Europe PMC DOI

hedged sentence

0.3600

closest p · 7.2× alpha

0.3600

boldest claim

The sentences

a weak trendp = 0.36not close (p > 0.1)

Our analysis of these data, although severely underpowered, did show a weak trend toward worse survival among HOXD12 gene body hypermethylated patients in both overall survival (HR = 2.8, p = 0.36) and progression-free survival (HR = 2.8, p = 0.36) (Supplemental Fig. 16).

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.